Wang et al. (2024) reported subclinical hypothyroidism in a male Ewing sarcoma patient treated with anti-PD-L1 [67], while Chang et al. (2019) documented low FSH and hypothyroidism in a female lung adenocarcinoma patient on nivolumab [68]. This evidence concerns the gene CD274 and lung adenocarcinoma.